ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
David S. Winlaw
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Winlaw, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Winlaw, D. S.

Ann Thorac Surg 1997;64:1204-1211
© 1997 The Society of Thoracic Surgeons


Current review

Angiogenesis in the Pathobiology and Treatment of Vascular and Malignant Diseases

David S. Winlaw, MD, BS

Department of Vascular Surgery and Molecular Genetics Unit, Kolling Institute for Medical Research, Royal North Shore Hospital, Sydney, Australia

Cardiovascular disease and cancer account for the majority of adult disease in the developed world. This review focuses on current concepts in the study of angiogenesis (new vessel formation) as related to these conditions and highlights the role of vascular endothelial growth factor. Developments in therapeutic angiogenesis have raised the possibility that pharmacologic or gene-directed interventions, based on the ability of vascular endothelial growth factor to promote new vessel formation, may soon gain clinical application for the treatment of occlusive vascular disease. Similarly, the future treatment of malignant disease is likely to involve antiangiogenic agents that, in preliminary animal work, have demonstrated an efficacy that is not limited by adverse affects. Aside from these potential applications, current investigations have enhanced our understanding of mechanisms involved in the development of atherosclerotic and malignant disease.




This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
A. Jackson, A. Kassner, D. Annesley-Williams, H. Reid, X.-P. Zhu, and K.-L. Li
Abnormalities in the Recirculation Phase of Contrast Agent Bolus Passage in Cerebral Gliomas: Comparison with Relative Blood Volume and Tumor Grade
AJNR Am. J. Neuroradiol., January 1, 2002; 23(1): 7 - 14.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. G. Favaloro
Landmarks in the Development of Coronary Artery Bypass Surgery
Circulation, August 4, 1998; 98(5): 466 - 478.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1997 by The Society of Thoracic Surgeons.